Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-07-09 Purchase | 2024-07-11 4:15 pm | Alto Neuroscience Inc. | ANRO | Savitz Adam CHIEF MEDICAL OFFICER | 15,000 | $12.72 | $190,833 | 39,851 (Indirect) | View |
| 2024-03-28 Purchase | 2024-04-01 4:15 pm | Alto Neuroscience Inc. | ANRO | Smith Nicholas Conrad CHIEF FINANCIAL OFFICER | 6,150 | $16.36 | $100,628 | 26,866 (Direct) | View |
| 2024-02-06 Purchase | 2024-02-08 4:32 pm | Alto Neuroscience Inc. | ANRO | Alpha Wave Global LP Alpha Wave Ventures GP Ltd Lunate Holding RSC Ltd Chimera Investment LLC 10% Owner | 600,000 | $16 | $9,600,000 | 3,707,757 (Indirect) | View |
| 2024-02-06 Purchase | 2024-02-07 4:40 pm | Alto Neuroscience Inc. | ANRO | Smith Nicholas Conrad CHIEF FINANCIAL OFFICER | 1,563 | $16 | $25,008 | 1,563 (Direct) | View |
| 2024-02-06 Purchase | 2024-02-07 4:38 pm | Alto Neuroscience Inc. | ANRO | Savitz Adam CHIEF MEDICAL OFFICER | 17,000 | $16 | $272,000 | 24,851 (Indirect) | View |
| 2024-02-06 Purchase | 2024-02-07 4:36 pm | Alto Neuroscience Inc. | ANRO | Etkin Amit PRESIDENT AND CEO | 3,125 | $16 | $50,000 | 1,205,465 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-05-20 Option Award | 2024-05-22 5:19 pm | N/A 2034-05-19 | Alto Neuroscience Inc. | ANRO | Hanley Jr. Michael Conick Chief Operating Officer | 188,000 | $0 | 188,000 (Direct) | View |
Ownership | 2024-05-22 5:17 pm | N/A 2034-02-28 | Alto Neuroscience Inc. | ANRO | Hanley Jr. Michael Conick Chief Operating Officer | 0 | $0 | 8,000 (Direct) | View |
| 2024-03-08 Option Award | 2024-03-12 4:49 pm | N/A 2034-03-07 | Alto Neuroscience Inc. | ANRO | Radhakrishnan Maha Director | 1,590 | $10.21 | 32,164 (Direct) | View |
| 2024-03-08 Option Award | 2024-03-12 4:49 pm | N/A 2034-03-07 | Alto Neuroscience Inc. | ANRO | Radhakrishnan Maha Director | 30,574 | $0 | 32,164 (Direct) | View |
| 2024-02-06 Conversion | 2024-03-06 09:15 am | N/A N/A | Alto Neuroscience Inc. | ANRO | Apeiron Investment Group Ltd. Apeiron Presight Capital Fund II L.P. Angermayer Christian See Remarks | 3,257,755 | $0 | 926,539 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-05 6:00 pm | N/A 2034-02-28 | Alto Neuroscience Inc. | ANRO | Savitz Adam CHIEF MEDICAL OFFICER | 73,000 | $0 | 73,000 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-05 6:00 pm | N/A 2034-02-28 | Alto Neuroscience Inc. | ANRO | Smith Nicholas Conrad CHIEF FINANCIAL OFFICER | 109,153 | $0 | 110,716 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-05 6:00 pm | N/A 2034-02-28 | Alto Neuroscience Inc. | ANRO | Etkin Amit PRESIDENT AND CEO | 257,711 | $0 | 1,463,176 (Direct) | View |
| 2024-02-06 Conversion | 2024-02-08 4:32 pm | N/A N/A | Alto Neuroscience Inc. | ANRO | Alpha Wave Global LP Alpha Wave Ventures GP Ltd Lunate Holding RSC Ltd Chimera Investment LLC 10% Owner | 4,252,520 | $0 | 3,707,757 (Indirect) | View |
| 2024-02-06 Conversion | 2024-02-07 4:41 pm | N/A N/A | Alto Neuroscience Inc. | ANRO | York Gwill Director | 77,113 | $0 | 23,917 (Direct) | View |
| 2024-02-06 Conversion | 2024-02-07 4:39 pm | N/A N/A | Alto Neuroscience Inc. | ANRO | Cox Christopher Nixon Director | 2,247,570 | $0 | 715,653 (Indirect) | View |
| 2024-02-06 Conversion | 2024-02-07 4:38 pm | N/A N/A | Alto Neuroscience Inc. | ANRO | Savitz Adam CHIEF MEDICAL OFFICER | 24,517 | $0 | 24,851 (Indirect) | View |
| 2024-02-06 Conversion | 2024-02-07 4:36 pm | N/A N/A | Alto Neuroscience Inc. | ANRO | Etkin Amit PRESIDENT AND CEO | 36,777 | $0 | 1,205,465 (Direct) | View |
| 2024-02-06 Conversion | 2024-02-07 4:35 pm | N/A N/A | Alto Neuroscience Inc. | ANRO | Chen Po Yu (Jeff) Director | 149,836 | $0 | 47,709 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-05 4:47 pm | N/A 2034-01-31 | Alto Neuroscience Inc. | ANRO | York Gwill Director | 30,574 | $0 | 33,657 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-05 4:47 pm | N/A 2034-01-31 | Alto Neuroscience Inc. | ANRO | York Gwill Director | 3,083 | $11.88 | 33,657 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-05 4:45 pm | N/A 2034-01-31 | Alto Neuroscience Inc. | ANRO | Manji Husseini Director | 30,574 | $0 | 33,657 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-05 4:45 pm | N/A 2034-01-31 | Alto Neuroscience Inc. | ANRO | Manji Husseini Director | 3,083 | $11.88 | 33,657 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-05 4:43 pm | N/A 2034-01-31 | Alto Neuroscience Inc. | ANRO | Chen Po Yu (Jeff) Director | 30,574 | $0 | 32,114 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-05 4:43 pm | N/A 2034-01-31 | Alto Neuroscience Inc. | ANRO | Chen Po Yu (Jeff) Director | 1,540 | $11.88 | 32,114 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-05 4:42 pm | N/A 2034-01-31 | Alto Neuroscience Inc. | ANRO | Cox Christopher Nixon Director | 30,574 | $0 | 35,197 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-05 4:42 pm | N/A 2034-01-31 | Alto Neuroscience Inc. | ANRO | Cox Christopher Nixon Director | 4,623 | $11.88 | 35,197 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-05 4:40 pm | N/A 2034-01-31 | Alto Neuroscience Inc. | ANRO | Dreyfus Andrew Director | 30,574 | $0 | 30,574 (Direct) | View |
Ownership | 2024-02-02 4:54 pm | N/A N/A | Alto Neuroscience Inc. | ANRO | Apeiron Investment Group Ltd. Angermayer Christian Apeiron Presight Capital Fund II L.P. 10% Owner | 0 | $0 | 2,933,173 (Direct) | View |
Ownership | 2024-02-01 6:53 pm | N/A 2033-10-11 | Alto Neuroscience Inc. | ANRO | Dreyfus Andrew Director | 0 | $0 | 22,481 (Direct) | View |
Ownership | 2024-02-01 6:53 pm | N/A N/A | Alto Neuroscience Inc. | ANRO | Alpha Wave Ventures GP Ltd Alpha Wave Global LP Lunate Holding RSC Ltd Chimera Investment LLC 10% Owner | 0 | $0 | 3,107,757 (Indirect) | View |
Ownership | 2024-02-01 6:52 pm | N/A N/A | Alto Neuroscience Inc. | ANRO | Etkin Amit President and CEO | 0 | $0 | 1,641,617 (Direct) | View |
Ownership | 2024-02-01 6:50 pm | N/A N/A | Alto Neuroscience Inc. | ANRO | York Gwill Director | 0 | $0 | 68,878 (Direct) | View |
Ownership | 2024-02-01 6:48 pm | N/A 2031-09-08 | Alto Neuroscience Inc. | ANRO | Smith Nicholas Conrad Chief Financial Officer | 0 | $0 | 416,010 (Direct) | View |
Ownership | 2024-02-01 6:47 pm | N/A N/A | Alto Neuroscience Inc. | ANRO | ALKEON CAPITAL MANAGEMENT LLC See Remarks | 0 | $0 | 477,101 (Direct) | View |
Ownership | 2024-02-01 6:47 pm | N/A N/A | Alto Neuroscience Inc. | ANRO | Cox Christopher Nixon Director | 0 | $0 | 715,653 (Indirect) | View |
Ownership | 2024-02-01 6:45 pm | N/A N/A | Alto Neuroscience Inc. | ANRO | Savitz Adam Chief Medical Officer | 0 | $0 | 321,871 (Indirect) | View |
Ownership | 2024-02-01 6:43 pm | N/A N/A | Alto Neuroscience Inc. | ANRO | Chen Po Yu (Jeff) Director | 0 | $0 | 47,709 (Direct) | View |